Abstract / Summary
Transdermal testosterone absorption depends strongly on the application site and is not proportional to the applied dose, yet dose planning for compounded testosterone creams is often done as if a fixed percentage were absorbed at every dose. This note describes the cream model used in the TRT Plus app. Weekly absorbed testosterone is computed from the weekly applied dose with a site-specific Michaelis-Menten saturation function, so the absorbed fraction falls as the dose rises. The absorbed amount is converted to an injectable-ester equivalent for comparison with injected protocols, and divided equally across applications to drive a one-compartment first-order absorption and elimination model. Superposition of applications is simulated explicitly to estimate steady-state peak-to-trough fluctuation and time to peak. Five application sites are supported: scrotum, shoulders/arms, abdomen, axilla and inner thighs. We give the formal model, the rationale, simulation conventions and limitations. Per-site model constants are calibrated values and are withheld. The model has not been validated against measured serum concentrations in TRT Plus users and is published as a methods description, not as clinical or dosing guidance.